X-ray and cryo-EM structures of inhibitor-bound cytochrome bc1 complexes for structure-based drug discovery

被引:20
|
作者
Amporndanai, Kangsa [1 ]
Johnson, Rachel M. [2 ,3 ,4 ]
O'Neill, Paul M. [5 ]
Fishwick, Colin W. G. [3 ,4 ]
Jamson, Alexander H. [2 ,3 ]
Rawson, Shaun [2 ,3 ]
Muench, Stephen P. [2 ,3 ]
Hasnain, S. Samar [1 ]
Antonyuk, Svetlana V. [1 ]
机构
[1] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England
[2] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, Astbury Ctr Struct & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[4] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England
[5] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England
来源
IUCRJ | 2018年 / 5卷
基金
英国惠康基金;
关键词
cryo-electron microscopy; cryo-EM; membrane proteins; electron-transport chain; malaria; cytochrome bc(1); MITOCHONDRIAL ELECTRON-TRANSPORT; 2.3 ANGSTROM RESOLUTION; PLASMODIUM-FALCIPARUM; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; SITE INHIBITORS; PROTEIN; ATOVAQUONE; MECHANISM; ANTIMALARIALS;
D O I
10.1107/S2052252518001616
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cytochrome bc(1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc(1) from mammalian homologues co-crystallized with lead compounds have underpinned structure-based drug design to develop compounds with higher potency and selectivity. However, owing to the limited amount of cytochrome bc(1) that may be available from parasites, all efforts have been focused on homologous cytochrome bc(1) complexes from mammalian species, which has resulted in the failure of some drug candidates owing to toxicity in the host. Crystallographic studies of the native parasite proteins are not feasible owing to limited availability of the proteins. Here, it is demonstrated that cytochrome bc(1) is highly amenable to single-particle cryo-EM (which uses significantly less protein) by solving the apo and two inhibitor-bound structures to similar to 4.1 angstrom resolution, revealing clear inhibitor density at the binding site. Therefore, cryo-EM is proposed as a viable alternative method for structure-based drug discovery using both host and parasite enzymes.
引用
收藏
页码:200 / 210
页数:11
相关论文
共 26 条
  • [21] Recent advances in DDAH1 inhibitor design and discovery: insights from structure-activity relationships and X-ray crystal structures
    Doman, Anthony J.
    Perkins, Michael V.
    Tommasi, Sara
    Mangoni, Arduino A.
    Nair, Pramod C.
    RSC ADVANCES, 2024, 14 (14) : 9619 - 9630
  • [22] X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17
    Drinkwater, Nyssa
    Bamert, Rebecca S.
    Sivaraman, Komagal Kannan
    Paiardini, Alessandro
    McGowan, Sheena
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2015, 83 (04) : 789 - 795
  • [23] Structure-Based Design of Potent HIV-1 Protease Inhibitors with Modified P1-Biphenyl Ligands: Synthesis, Biological Evaluation, and Enzyme-Inhibitor X-ray Structural Studies
    Ghosh, Arun K.
    Yu, Xufen
    Osswald, Heather L.
    Agniswamy, Johnson
    Wang, Yuan-Fang
    Arnano, Masayuki
    Weber, Irene T.
    Mitsuya, Hiroaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (13) : 5334 - 5343
  • [24] Structure-based design, synthesis, biological evaluation, and x-ray crystallographic analysis of novel, highly potent HIV-1 protease inhibitors to address multi-drug resistant HIV
    Ghosh, Arun
    Osswald, Heather
    Agniswamy, Johnson
    Wang, Yuan-Fang
    Weber, Irene
    Amano, Masayuki
    Mitsuya, Hiroaki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [25] X-ray crystallographic analysis of IMP-1 metallo-β-lactamase complexed with a 3-aminophthalic acid derivative, structure-based drug design, and synthesis of 3,6-disubstituted phthalic acid derivative inhibitors
    Hiraiwa, Yukiko
    Saito, Jun
    Watanabe, Takashi
    Yamada, Mototsugu
    Morinaka, Akihiro
    Fukushima, Takayoshi
    Kudo, Toshiaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (20) : 4891 - 4894
  • [26] Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design
    Wyatt, Paul G.
    Woodhead, Andrew J.
    Berdini, Valerio
    Boulstridge, John A.
    Carr, Maria G.
    Cross, David M.
    Davis, Deborah J.
    Devine, Lindsay A.
    Early, Theresa R.
    Feltell, Ruth E.
    Lewis, E. Jonathan
    McMenamin, Rachel L.
    Navarro, Eva F.
    O'Brien, Michael A.
    O'Reilly, Marc
    Reule, Matthias
    Saxty, Gordon
    Seavers, Lisa C. A.
    Smith, Donna-Michelle
    Squires, Matt S.
    Trewartha, Gary
    Walker, Margaret T.
    Woolford, Alison J. -A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 4986 - 4999